Active	Status	Sponsor type	Region	Phase	Filter
9 Active 3 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Meuth, Sven
NCT05798520: A Study to Evaluate Safety and Efficacy of BIIB091 in Participants With Relapsing Forms of Multiple Sclerosis	Recruiting	2	275	Europe, US, RoW	BIIB091, DRF, Placebo	Biogen	Relapsing Forms of Multiple Sclerosis	07/25	11/26
Pawlitzki, Marc
SATURATE-MS, NCT05701423: A Study of End of Dose Phenomena in Subcutaneous Natalizumab Treated Multiple Sclerosis (MS) Participants	Active, not recruiting	N/A	34	Europe	Natalizumab, Tysabri	Biogen	Multiple Sclerosis	07/24	07/24
Rolfes, Leoni
No trials found